Anaphylatoxin c5a induces monocyte recruitment and differentiation into dendritic cells by TNF-α and prostaglandin E2-dependent mechanisms

被引:56
作者
Soruri, A
Riggert, J
Schlott, T
Kiafard, Z
Dettmer, C
Zwirner, J
机构
[1] Univ Gottingen, Dept Immunol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Dept Cytopathol, D-3400 Gottingen, Germany
[3] Univ Gottingen, Dept Transfus Med, D-3400 Gottingen, Germany
关键词
D O I
10.4049/jimmunol.171.5.2631
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although monocytes can be directed to develop into dendritic cells (DC) in vitro, the molecular mechanisms that induce their transformation in vivo are largely unknown. In the present study we employed an in vivo SCID mouse model to investigate the impact of two proinflammatory chemotaxins, the anaphylatoxin C5a and the chemokine macrophage inflammatory protein-1alpha (CCL3), on the differentiation of human monocytes and immature DC generated from monocytes in the presence of GM-CSF and IL-4. Both C5a and macrophage inflammatory protein-1alpha recruited human monocytes and immature DC into the peritoneal cavity of SCID mice, but only C5a induced their differentiation into phenotypically mature DC by 48 h after injection. Macrophages derived from monocytes by in vitro culture were resistant to C5a-mediated transformation in vivo. The effect of C5a was indirect, since C5a-stimulated TNF-alpha and PGE(2) were found to be obligatory as well, as sufficient to induce differentiation of monocytes. In contrast to monocytes, in vitro generated immature DC required TNF-alpha, but not PGE(2), for their C5a-mediated maturation in vivo. C5a-transformed monocytes represented an inflammatory type of DC, as they constitutively secreted high amounts of TNF-alpha, but also retained the capacity to release the Th1 cytokine IL-12 p70 upon stimulation with CD40 ligand. In summary, we identified for the first time a cascade of inflammatory signals that can induce the transformation of monocytes into DC in vivo. This novel function emphasizes the important immunoregulatory role of C5a at the interface of innate and adaptive immunity.
引用
收藏
页码:2631 / 2636
页数:6
相关论文
共 45 条
[1]   Dendritic cells as vectors for therapy [J].
Banchereau, J ;
Schuler-Thurner, B ;
Palucka, AK ;
Schuler, G .
CELL, 2001, 106 (03) :271-274
[2]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]  
BETZ M, 1991, J IMMUNOL, V146, P108
[5]   EXPRESSION CLONING OF A RECEPTOR FOR C5A ANAPHYLATOXIN ON DIFFERENTIATED HL-60 CELLS [J].
BOULAY, F ;
MERY, L ;
TARDIF, M ;
BROUCHON, L ;
VIGNAIS, P .
BIOCHEMISTRY, 1991, 30 (12) :2993-2999
[6]   Dendritic cell biology and regulation of dendritic cell trafficking by chemokines [J].
Caux, C ;
Ait-Yahia, S ;
Chemin, K ;
de Bouteiller, O ;
Dieu-Nosjean, MC ;
Homey, B ;
Massacrier, C ;
Vanbervliet, B ;
Zlotnik, A ;
Vicari, A .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2000, 22 (04) :345-369
[7]   RECOMBINANT C5A ENHANCES INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR RELEASE BY LIPOPOLYSACCHARIDE-STIMULATED MONOCYTES AND MACROPHAGES [J].
CAVAILLON, JM ;
FITTING, C ;
HAEFFNERCAVAILLON, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (02) :253-257
[8]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752
[9]  
Cooper, 1999, Inflammation: Basic principles and clinical correlates, V3rd, P281
[10]   Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites [J].
Dieu, MC ;
Vanbervliet, B ;
Vicari, A ;
Bridon, JM ;
Oldham, E ;
Aït-Yahia, S ;
Brière, F ;
Zlotnik, A ;
Lebecque, S ;
Caux, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :373-386